Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000003

Chief Commercial Officer gave up 725 shares (to pay taxes)

  • Chief Commercial Officer acquired 2,068 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Poddar Richa Chief Commercial Officer 2022-02-10 Option exercise +2,068 2,218 D: show line 1 in the form
Poddar Richa Chief Commercial Officer 2022-02-10 Shares withheld for taxes −725 $31.43 $22,783 1,493 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Poddar Richa Chief Commercial Officer 2022-02-10 Option exercise · Restricted stock units −2,068 4,136 D: show line 3 in the form
Loading xslF345X03/wf-form4_164487275264401.xml…